You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 31 Next »

Project Statement 
Transparency initiatives allow public scrutiny and research in the application of new knowledge based on clinical data. Current GxP guidelines do not apply to transparency as it represents a different flow of data in which anonymisation is carried out on a copy of the regulated data.
Project Statement 
Transparency initiatives allow public scrutiny and research in the application of new knowledge based on clinical data. Current GxP guidelines do not apply to transparency as it represents a different flow of data in which anonymisation is carried out on a copy of the regulated data.
Project Impact
Good Transparency Practices (GTP) would provide a means to achieving accountability and traceability while providing reasonable assurance that privacy requirements are being upheld.


Project LeadsEmail

Lauren Hepburn (Iconic)

lauren.hepburn@iconplc.com

Abby McDonell (Privacy Analytics)

amcdonell@privacy-analytics.com

Paula Rowley (PHUSE Project Assistant)paula@phuse.global 
Objectives & Deliverables Timelines
Good Transparency Practices guidance documentQ3 2022

CURRENT STATUSQ2/3 2022

  • Group are completing current background research and organising notes to prepare for writing the GTP guidance.
  • Successfully solicited involvement from the EMA and Health Canada.
  • Group are beginning the first draft of GTP guidance.


Project MembersOrganisation
Abhinav SrivastvaExelixis
Andre MolgatHealth Canada 
Benjamin C ShimEli Lilly
Brenda TiffinClaritidox
Cara CamporaBeigene
Devaki ThavarajahIndustry
Dhiraj DabhiEli Lilly
Mahesh SwaminathanBristol Myers Squibb
Manohara Basoor HalasiddappaAlgok Bio
Mekhala AcharyaTakeda
Sanjay Bagani Xogene 
Sarah BalayPrivacy Analytics
Sharon NiedeckenPfizer
Shannon LefaivreRoche
Shweta SrivastavaXogene 
Sophia ZilberPfizer
Rama EmpatiAstrazeneca


  • No labels